Verinurad is used in the treatment of gout and hyperuricemia. It works by selectively inhibiting the URAT1 transporter in the kidneys, which helps increase uric acid excretion and lower serum uric acid levels. It is often studied in combination with xanthine oxidase inhibitors like allopurinol or febuxostat to enhance uric acid reduction in patients who do not reach target levels with monotherapy. This makes it a potential option for managing chronic gout where standard treatments are insufficient.